Astrana Health, Inc. (ASTH)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 370 | 774 | 1,144 | 1,387 | 2,035 | 3,182 | 3,844 | 3,982 |
| Operating profit | $m | 79 | 100 | ||||||
| Net profit | $m | -24 | 69 | 45 | 61 | 43 | 22 | 41 | 70 |
| EPS reported | $ | 0.46 | 0.82 | ||||||
| Operating cashflow per share | $ | 2.34 | 3.58 | ||||||
| Capex per share | $ | 0.21 | 0.36 | ||||||
| FCF per share | $ | 2.13 | 3.23 | ||||||
| Free cash flow | $m | 104 | 158 | ||||||
| Net debt | $m | 609 | 536 | ||||||
| Book value equity | $m | 779 | 830 | ||||||
| Book value per share | $ | 15.78 | 16.68 | ||||||
| Number of shares | m | 49.37 | 49.78 | ||||||
| DPS (TTM paid) | $ | 0.16 | 0.04 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | 53.93 | 44.49 | ||||||
| P/B LTM | x | 1.56 | 1.47 | ||||||
| P/S LTM | x | 0.38 | 0.32 | ||||||
| P/FCF LTM | x | 11.65 | 7.68 | ||||||
| EV/EBITDA LTM | x | 13.79 | 10.67 | ||||||
| EV/Sales LTM | x | 0.59 | 0.65 | ||||||
| Earnings Yield LTM | % | +1.85% | +2.25% | ||||||
| FCF Yield | % | +8.58% | +13.01% | ||||||
| Quality | |||||||||
| ROE | % | +2.89% | +5.09% | ||||||
| ROIC | % | +2.88% | +4.10% | ||||||
| Operating margin | % | +2.47% | +2.61% | ||||||
| Gross margin | % | +9.30% | +9.22% | ||||||
| FCF/Sales | % | +3.28% | +4.12% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | -48.89% | -8.89% | ||||||
| Sales Growth YoY | % | +56.39% | +88.95% | ||||||
| Net Income Growth YoY | % | -47.89% | -6.03% | ||||||
| FCF Growth | % | +136.58% | +258.72% | ||||||
| Operating Profit Growth | % | -12.12% | +12.43% | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | +0.65% | 0.00% | ||||||
| Dividend Growth | % | +90.83% | -53.07% | ||||||
| Payout Ratio | % | +34.72% | +4.84% | ||||||
| FCF/Debt | x | 0.10 | 0.16 | ||||||
| Net Debt/EBITDA | x | 4.79 | 3.31 | ||||||
| EBIT/Net interest | x | 1.57 | 1.49 | ||||||
| Net debt/market cap | % | +85.32% | +49.10% | ||||||
| Net debt/Equity | x | 0.78 | 0.65 | ||||||
| Gross debt/equity | x | 1.38 | 1.18 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Astrana Health, Inc., which rebranded from Apollo Medical Holdings, Inc. in February 2024, is a healthcare management firm based in Alhambra, California, founded in 1985. This company delivers medical services throughout the United States, operating with a physician-centered approach powered by advanced technology. Its operations are structured across three distinct divisions: Care Partners, Care Delivery, and Care Enablement. Astrana Health utilizes its exclusive platform for population health management and healthcare delivery to implement an integrated, value-based care model. This strategic approach empowers the healthcare providers within its network to offer high-quality care to their patients. The organization provides extensive care coordination services to a broad spectrum of stakeholders, including patients, their families, primary care physicians, specialists, acute care hospitals, other inpatient facilities, physician groups, and health plans. Its robust physician network encompasses primary care doctors, specialized practitioners, advanced practice providers (extenders), and hospital-based physicians. Astrana Health serves a diverse patient base, primarily those with insurance coverage—such as private plans, Medicare, Medicaid, and HMOs—but also extends care to uninsured individuals.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Astrana Health, Inc., which rebranded from Apollo Medical Holdings, Inc. in February 2024, is a healthcare management firm based in Alhambra, California, founded in 1985. This company delivers medical services throughout the United States, operating with a physician-centered approach powered by advanced technology. Its operations are structured across three distinct divisions: Care Partners, Care Delivery, and Care Enablement. Astrana Health utilizes its exclusive platform for population health management and healthcare delivery to implement an integrated, value-based care model. This strategic approach empowers the healthcare providers within its network to offer high-quality care to their patients. The organization provides extensive care coordination services to a broad spectrum of stakeholders, including patients, their families, primary care physicians, specialists, acute care hospitals, other inpatient facilities, physician groups, and health plans. Its robust physician network encompasses primary care doctors, specialized practitioners, advanced practice providers (extenders), and hospital-based physicians. Astrana Health serves a diverse patient base, primarily those with insurance coverage—such as private plans, Medicare, Medicaid, and HMOs—but also extends care to uninsured individuals.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free